Multi-Phase Validation of a New Biotech Diagnostic
The new diagnostic lacked systematic validation to prove clinical reliability.
Analytical validation → clinical validation → traceable reporting, closed loop by stage.
A biotech team (placeholder)
Biotech
Analytical Testing & Validation
We break down a multi-phase validation process for a rapid PCR assay, reaching clinical-grade reliability for rare-disease diagnostics.
The Challenge
The rapid PCR assay had promise but lacked the systematic validation to prove clinical-grade reliability.
Solution
We split validation into a closed loop of three phases: analytical validation, clinical validation, and traceable reporting — each closing on a defined metric.
Result
The tool reached clinical-grade reliability, cut validation time well below the industry benchmark, and passed internal and external review.
“Phased validation gave every step a basis in evidence — review was almost frictionless.”
.png)